-
Forward Look
An Overlooked Long-Term Side EffectQ&A with Patricia Ganz on chemotherapy-related nerve damage.
by Sue Rochman
-
Study Shows Minority Participation in Clinical Trials May Be Declining
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
From the Editor-in-Chief
Metabolism and CancerCan cancer's dependence on sugar help researchers find new targets to treat the disease?
by William G. Nelson, MD, PhD
-
Forward Look
Your Tax Dollars at WorkQ&A with Joseph Unger on publicly funded cancer research.
by Sue Rochman
-
Forward Look
Opportunities for PreventionInteractive maps and charts illustrate how many cancers are caused by infections worldwide.
by Sue Rochman
-
Vaccines: Looking Within for Cancer Treatment
Researchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
-
Cancer Control in the Community
Successful public health initiatives to prevent, detect and treat cancer require widespread community participation.
by Marci A. Landsmann
-
Healthy Habits
Vitamin D DoubtsIn a clinical trial, vitamin D supplements did not appear to reduce cancer risk.
by Jane C. Hu
-
Forward Look
Tinkering With T CellsNew cancer treatments use patients' own modified immune cells.
by Kate Yandell
Cancer Talk
Physical Activity Linked to Lower Colon Cancer Recurrence
Participating in a structured exercise program after treatment was associated with a reduced risk of recurrence in people who had colon cancer.
by Sandra Gordon
Gaps in Survivorship Care Leave Unmet Needs After Cancer TreatmentA survey of head and neck cancer survivors reveals that many are not getting adequate survivorship care and may not even know it is available.
by Cameron Walker
Improving Communication for Deaf Cancer PatientsAfter a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose